IGHE and food allergy: Additionally, a recruiting clinical trial (NCT06369467) is evaluating linvoseltamab—a novel anti-IgE monoclonal antibody—in combination with dupilumab in adults with severe IgE-mediated food allergies, including shellfish, offering a potential avenue for future targeted therapies.